C07K 14/212
Moraxellaceae
Official title: {Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter}
C07K14/212 (Moraxellaceae) appears on 118 US grants and 111 published applications in this corpus.
Search patents in C07K- Granted patents
- 118
- Published applications
- 111
- Assignees
- 64
- Inventors
- 192
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 5 | 0 |
| 1999 | 7 | 0 |
| 2000 | 3 | 0 |
| 2001 | 5 | 1 |
| 2002 | 9 | 3 |
| 2003 | 5 | 7 |
| 2004 | 6 | 8 |
| 2005 | 2 | 9 |
| 2006 | 3 | 5 |
| 2007 | 4 | 5 |
| 2008 | 8 | 2 |
| 2009 | 5 | 8 |
| 2010 | 4 | 6 |
| 2011 | 3 | 2 |
| 2012 | 2 | 4 |
| 2013 | 3 | 4 |
| 2014 | 5 | 1 |
| 2015 | 0 | 2 |
| 2016 | 1 | 4 |
| 2017 | 3 | 4 |
| 2018 | 4 | 12 |
| 2019 | 4 | 4 |
| 2020 | 8 | 5 |
| 2021 | 3 | 4 |
| 2022 | 1 | 5 |
| 2023 | 1 | 2 |
| 2024 | 3 | 2 |
| 2025 | 2 | 1 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Molecular strategy to protect against desiccation28 Jul 2026US 12,692,292 B2Vanderbilt University
- Glycosylated comp pilin variants, methods of making and uses thereof17 Mar 2026US 12,577,280 B2Vaxnewmo LLC
- O-linked glycosylation recognition motifs8 Jul 2025US 12,350,342 B2Vaxnewmo LLC
- Acinetobacter baumannii immunogenic protein and composition and application thereof18 Feb 2025US 12,227,545 B2Chengdu Olymvax Biopharmaceuticals Inc.
- Use of recombinant antibacterial protein Ablysin for effectively killing multidrug-resistant pathogenic bacteria1 Oct 2024US 12,102,666 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Acinetobacter vaccine and method of use thereof9 Jul 2026US 2026/0191944 A1Washington University
- Immunogenic compositions and methods for reducing transmission of pathogens2 Oct 2025US 2025/0302937 A1St. Jude Children?S Research Hospital
- Glycosylated comp pilin variants, methods of making and uses thereof8 Aug 2024US 2024/0262870 A1Vaxnewmo LLC
- Peptides derived from acinetobacter baumannii and their use in vaccination11 Jul 2024US 2024/0226263 A1Evaxion Biotech A/S
- A molecular strategy to protect against desiccation14 Sep 2023US 2023/0287059 A1Vanderbilt University
Most cited
By later US patents
- Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories181US 5,994,066 AInfectio Diagnostic, Inc. · 1999
- Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories178US 6,001,564 AInfectio Diagnostic, Inc. · 1999
- Protein having cell growth stimulating action, composition thereof and method for producing the same36US 4,604,234 ASanwa Kagaku Kenyusho Co., Ltd. · 1986
- Vaccine for Moraxella catarrhalis26US 5,948,412 AThe Research Foundation of State University of New York · 1999
- Outer membrane protein B1 of Moraxella catarrhalis20US 6,004,562 AThe Research Foundation of State University of New York · 1999